Jubilant Pharmova Limited (JUBLPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 129.37B |
| Enterprise Value | 152.84B |
| P/E Ratio | 44.2 |
| PEG Ratio | -1.89 |
| Price/Sales Ratio | 1.81 |
| Price/Book Ratio | 2.19 |
| Enterprise/Revenue | 1.81 |
| Enterprise/EBITDA | 12.84 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 82.8B |
| Revenue/Share | 543.5 |
| Gross Profit | 24.94B |
| EBITDA | 12.66B |
| Net Income | 3.99B |
| Diluted EPS | 25.08 |
Balance Sheet
| Total Cash | 12.67B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 447.99 |
Price History
| 52-Week Change | -13.76 |
| 52-Week High | 1,162 |
| 52-Week Low | 786.05 |
| Moving Average 50 Days | 978.52 |
| Moving Average 200 Days | 941.03 |
Statistics
| Average Volume | 277,188 |
| Shares Outstanding | 158.41M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 0.51 |
| Payout Ratio | 0.22 |
| Last Split Factor | 21:20 |
| Last Split Date | November 25, 2010 |
AD
